aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
2.990
-0.050 (-1.64%)
At close: Nov 20, 2024, 4:00 PM
2.931
-0.059 (-1.97%)
After-hours: Nov 20, 2024, 4:50 PM EST
aTyr Pharma Revenue
aTyr Pharma had revenue of $235.00K in the twelve months ending September 30, 2024, down -97.81% year-over-year. In the year 2023, aTyr Pharma had annual revenue of $353.00K, down -96.60%.
Revenue (ttm)
$235.00K
Revenue Growth
-97.81%
P/S Ratio
n/a
Revenue / Employee
$3,983
Employees
59
Market Cap
226.63M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionATYR News
- 5 days ago - aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis - GlobeNewsWire
- 27 days ago - aTyr Pharma: The Bull Has Finally Come Out - Seeking Alpha
- 5 weeks ago - aTyr Pharma to Present at the LD Micro Main Event XVII in October - Newsfile Corp
- 2 months ago - aTyr Pharma: Two 2025 Data Readouts Could Provide Inflection Point - Seeking Alpha
- 3 months ago - aTyr Pharma to Participate in September Investor Conferences - GlobeNewsWire
- 3 months ago - aTyr Pharma Announces Second Quarter 2024 Results and Provides Corporate Update - GlobeNewsWire
- 6 months ago - aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR” - GlobeNewsWire
- 6 months ago - aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire